NCT00364988View on ClinicalTrials.gov

Pioglitazone and Losartan Provides Additional Renoprotection

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

January 31, 2006

Conditions
Type 2 DiabetesDiabetic Nephropathy
Interventions
DRUG

pioglitazone+losartan

Pioglitazone (30 mg/daily) losartan (100 mg daily)

DRUG

losartan

losartan (100 mg daily)

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT00364988 - Pioglitazone and Losartan Provides Additional Renoprotection | Biotech Hunter | Biotech Hunter